31 phenotypes from 3 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Wrnb2b3121.1Clo/Wrnb2b3121.1Clo C57BL/6J-Wrnb2b3121.1Clo	abnormal cardiovascular development	J:175213
	bicuspid aortic valve	J:175213
	bicuspid pulmonary valve	J:175213
	cleft palate	J:175213
	enlarged adrenal glands	J:175213
	thymus hypoplasia	J:175213
Wrntm1Led/Wrn+ involves: 129S6/SvEvTac * Black Swiss	cardiac interstitial fibrosis	J:106446
Wrntm1Led/Wrntm1Led B6.129S6(BKSW)-Wrntm1Led	aortic valve stenosis	J:106446
	cardiac interstitial fibrosis	J:106446
	decreased systemic arterial diastolic blood pressure	J:106446
	hyperglycemia	J:106446
	hyperlipidemia	J:106446
	increased abdominal adipose tissue amount	J:106446
	increased cellular sensitivity to oxidative stress	J:106446
	increased circulating cholesterol level	J:106446
	increased circulating hyaluronic acid level	J:106446
	increased circulating insulin level	J:106446
	increased circulating triglyceride level	J:106446
	increased inguinal fat pad weight	J:106446
	increased left ventricle systolic pressure	J:106446
	increased retroperitoneal fat pad weight	J:106446
	increased susceptibility to age related obesity	J:106446
	insulin resistance	J:106446
	oxidative stress	J:106446
Wrntm1Led/Wrntm1Led either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * NIH Black Swiss)	increased tumor incidence	J:48424
	preweaning lethality, incomplete penetrance	J:48424
Wrntm1Led/Wrntm1Led involves: 129S6/SvEvTac * Black Swiss	abnormal thrombosis	J:106446
	cardiac interstitial fibrosis	J:106446
	heart inflammation	J:106446
	increased susceptibility to infection	J:106446
	increased tumor incidence	J:106446
Wrntm1Lgu/Wrntm1Lgu B6J.Cg-Wrntm1Lgu	decreased bone volume	J:213181
	increased osteoclast cell number	J:213181
Wrntm1Lgu/Wrntm1Lgu involves: BALB/c	abnormal cell physiology	J:61567